Longeveron (LGVN) news

Longeveron: 1-for-10 reverse stock split

Longeveron Inc. has announced a 1-for-10 reverse stock split of its outstanding common shares. The move is intended to increase the stock price to meet minimum listing requirements and potentially improve the company’s marketability and investor appeal. The reverse stock split will reduce the total…

Longeveron - Marie Washburn succeeds Lisa Locklear as CFO

Longeveron granted small or medium-sized enterprise (SME) status by the European Medicines Agency (EMA)

Longeveron, a biopharmaceutical company, has been granted small or medium-sized enterprise (SME) status by the European Medicines Agency (EMA). This classification aligns with the EMA’s SME criteria, which define SMEs as companies with fewer than 250 employees and an annual turnover or balance…

Longeveron - anticipates Marie Washburn to be elevated to CFO pending final contract - SEC filing

Longeveron Inc. has announced that Marie Washburn is anticipated to be elevated to the role of Chief Financial Officer (CFO), pending the finalization of her contract, according to a recent SEC filing. Washburn, who has previously held significant financial leadership roles within the company, is…

Longeveron - on June 1, Lisa Locklear to step down as CFO effective July 10, 2026 - SEC filing

Longeveron Inc. (NASDAQ: LGVN) has announced that Lisa Locklear, its Chief Financial Officer, will step down from her role effective July 10, 2026, as disclosed in a recent SEC filing . Locklear, who joined Longeveron in 2023, brought extensive financial leadership experience to the company,…